FUCUS VESICULOSUS

FUCUS VESICULOSUS was reported 2845 times

FUCUS VESICULOSUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THALASSAEMIA ALPHA 1 0.0303
1 PHOSPHOLIPIDOSIS 1 0.0101
2 ANAL POLYP 1 0.0097
3 CARDIOMYOPATHY ACUTE 2 0.0091
4 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 1 0.0089
5 MULTIPLE CHEMICAL SENSITIVITY 1 0.0075
6 BLOOD ALDOSTERONE INCREASED 1 0.0057
7 GINGIVAL OPERATION 1 0.0045
8 ELECTROCARDIOGRAM Q WAVE ABNORMAL 1 0.0043
9 POSTPARTUM DEPRESSION 1 0.0039
10 CHRONIC DISEASE 1 0.0039
11 BREAST DISORDER FEMALE 1 0.0039
12 EYELID OPERATION 1 0.0037
13 FACIAL WASTING 1 0.0037
14 PRODUCT IMPURITY 1 0.0036
15 MUMPS 1 0.0032
16 ALLERGY TO ARTHROPOD BITE 1 0.0031
17 DECREASED VIBRATORY SENSE 1 0.0029
18 HEMIHYPOAESTHESIA 1 0.0028
19 HERBAL INTERACTION 1 0.0028
20 LUNG CYST 1 0.0025
21 RAPID EYE MOVEMENTS SLEEP ABNORMAL 1 0.0024
22 TRANSFERRIN SATURATION DECREASED 1 0.0023
23 APTYALISM 2 0.0023
24 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
25 LACRIMATION DECREASED 1 0.0021
26 LIGAMENT PAIN 1 0.0019
27 SALIVARY GLAND ENLARGEMENT 1 0.0019
28 UTERINE INFECTION 1 0.0019
29 EYE INFECTION BACTERIAL 1 0.0018
30 COLON INJURY 1 0.0017
31 OXYGEN CONSUMPTION DECREASED 1 0.0017
32 PROLONGED LABOUR 1 0.0016
33 RECTAL FISSURE 1 0.0016
34 PERNICIOUS ANAEMIA 1 0.0016
35 MAMMOGRAM ABNORMAL 1 0.0015
36 MACULAR HOLE 2 0.0015
37 KERATOACANTHOMA 1 0.0015
38 ANGULAR CHEILITIS 1 0.0014
39 PAINFUL DEFAECATION 1 0.0014
40 PEPTIC ULCER HAEMORRHAGE 1 0.0014
41 MYOFASCIAL PAIN SYNDROME 1 0.0014
42 BITE 1 0.0014
43 LIPIDS ABNORMAL 1 0.0014
44 OTITIS MEDIA ACUTE 1 0.0014
45 LEGAL PROBLEM 1 0.0014
46 OBSTRUCTIVE PANCREATITIS 1 0.0013
47 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
48 ENTHESOPATHY 2 0.0013
49 PENILE HAEMORRHAGE 1 0.0012
50 CARDIAC STRESS TEST ABNORMAL 1 0.0012
51 CONGESTIVE CARDIOMYOPATHY 5 0.0012
52 PERIORBITAL PAIN 1 0.0012
53 HEPATIC HAEMORRHAGE 1 0.0012
54 URGE INCONTINENCE 1 0.0011
55 EMOTIONAL POVERTY 2 0.0011
56 EXPOSURE VIA DIRECT CONTACT 1 0.0011
57 RED BLOOD CELLS URINE POSITIVE 1 0.0010
58 DILATED CARDIOMYOPATHY 1 0.0010
59 BENIGN BREAST NEOPLASM 1 0.0010
60 METASTASES TO PLEURA 1 0.0010
61 SYSTOLIC DYSFUNCTION 1 0.0009
62 NAIL GROWTH ABNORMAL 1 0.0009
63 ACUTE PRERENAL FAILURE 1 0.0009
64 DILATATION ATRIAL 1 0.0009
65 BILE DUCT CANCER 1 0.0008
66 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
67 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
68 JOINT WARMTH 1 0.0008
69 TESTICULAR SWELLING 1 0.0008
70 SINUS ARRHYTHMIA 1 0.0008
71 TONGUE DRY 1 0.0007
72 LIP BLISTER 2 0.0007
73 CLUMSINESS 2 0.0007
74 MENINGITIS BACTERIAL 1 0.0007
75 INVESTIGATION ABNORMAL 1 0.0007
76 COCCYDYNIA 1 0.0007
77 EPICONDYLITIS 1 0.0007
78 NEOPLASM SKIN 1 0.0006
79 NASAL ULCER 1 0.0006
80 FOREIGN BODY SENSATION IN EYES 4 0.0006
81 PATHOLOGICAL GAMBLING 1 0.0006
82 VEIN RUPTURE 1 0.0006
83 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
84 SENSITIVITY OF TEETH 1 0.0006
85 BREAST DISCHARGE 1 0.0006
86 EMBOLIC STROKE 2 0.0006
87 FEAR OF DISEASE 1 0.0006
88 METASTATIC RENAL CELL CARCINOMA 1 0.0005
89 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
90 INJECTION SITE CELLULITIS 1 0.0005
91 BLOOD IRON INCREASED 1 0.0005
92 LIP DISORDER 1 0.0005
93 BILE DUCT OBSTRUCTION 1 0.0005
94 SPINAL CORD COMPRESSION 2 0.0005
95 JOINT CREPITATION 1 0.0005
96 CARDIAC DISCOMFORT 1 0.0005
97 LIPIDS INCREASED 1 0.0005
98 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
99 POLYCYTHAEMIA 1 0.0005
100 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
101 DILATATION VENTRICULAR 1 0.0005
102 CHAPPED LIPS 2 0.0005
103 PERIARTHRITIS 1 0.0004
104 DISLOCATION OF VERTEBRA 1 0.0004
105 EYELID DISORDER 1 0.0004
106 NEPHROGENIC ANAEMIA 2 0.0004
107 LACUNAR INFARCTION 1 0.0004
108 GASTROINTESTINAL OBSTRUCTION 1 0.0004
109 SLOW SPEECH 1 0.0004
110 BRONCHITIS CHRONIC 1 0.0004
111 HAEMATOLOGICAL INFECTION 1 0.0004
112 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
113 CARTILAGE INJURY 1 0.0004
114 OSTEITIS 1 0.0004
115 METASTASES TO PERITONEUM 1 0.0004
116 URINARY TRACT INFECTION BACTERIAL 1 0.0004
117 ENDODONTIC PROCEDURE 1 0.0004
118 PATHOLOGICAL FRACTURE 2 0.0004
119 BOWEL MOVEMENT IRREGULARITY 3 0.0004
120 TENDONITIS 6 0.0004
121 RETINAL DISORDER 1 0.0004
122 WHITE BLOOD CELL DISORDER 1 0.0004
123 WEIGHT BEARING DIFFICULTY 1 0.0004
124 HEART RATE ABNORMAL 2 0.0004
125 NECK MASS 1 0.0004
126 CEREBRAL THROMBOSIS 1 0.0004
127 PERONEAL NERVE PALSY 2 0.0004
128 DUODENAL ULCER HAEMORRHAGE 1 0.0003
129 HYPERTONIC BLADDER 1 0.0003
130 VOMITING PROJECTILE 1 0.0003
131 EYE PAIN 19 0.0003
132 CREPITATIONS 1 0.0003
133 CEREBROVASCULAR DISORDER 1 0.0003
134 EMERGENCY CARE 1 0.0003
135 BREAST CANCER RECURRENT 1 0.0003
136 POLYMYALGIA RHEUMATICA 1 0.0003
137 PLASMA CELL MYELOMA RECURRENT 1 0.0003
138 POSTURE ABNORMAL 1 0.0003
139 PHARYNGEAL SWELLING 3 0.0003
140 BREAST ENLARGEMENT 1 0.0003
141 SOMNAMBULISM 2 0.0003
142 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
143 VIITH NERVE PARALYSIS 1 0.0003
144 HAIR GROWTH ABNORMAL 2 0.0003
145 GRANULOMA 1 0.0003
146 TACHYPHRENIA 1 0.0003
147 DEFAECATION URGENCY 2 0.0003
148 LOGORRHOEA 1 0.0003
149 PULMONARY TOXICITY 2 0.0003
150 ASTHMATIC CRISIS 1 0.0003
151 BLOOD PHOSPHORUS DECREASED 1 0.0003
152 ALCOHOL USE 1 0.0003
153 IMPULSIVE BEHAVIOUR 1 0.0003
154 HEPATIC NECROSIS 1 0.0003
155 FACE INJURY 1 0.0003
156 CONCUSSION 2 0.0003
157 SENSATION OF HEAVINESS 1 0.0003
158 EPIGASTRIC DISCOMFORT 1 0.0003
159 ORAL INFECTION 1 0.0003
160 WOUND SECRETION 1 0.0003
161 NAIL DISCOLOURATION 1 0.0003
162 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
163 FOREIGN BODY 1 0.0002
164 INTRACRANIAL ANEURYSM 1 0.0002
165 ORGAN FAILURE 1 0.0002
166 FUNGAL SKIN INFECTION 1 0.0002
167 ENURESIS 1 0.0002
168 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
169 GOITRE 1 0.0002
170 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
171 VITAMIN D DECREASED 2 0.0002
172 PRODUCT DISPENSING ISSUE 1 0.0002
173 TONGUE DISCOLOURATION 1 0.0002
174 PULMONARY FUNCTION TEST DECREASED 1 0.0002
175 ONYCHOMYCOSIS 1 0.0002
176 GROIN PAIN 2 0.0002
177 PARONYCHIA 1 0.0002
178 HAEMORRHAGIC ANAEMIA 1 0.0002
179 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
180 CARDIOTOXICITY 2 0.0002
181 INJECTION SITE PAPULE 1 0.0002
182 EAR DISORDER 1 0.0002
183 INCREASED TENDENCY TO BRUISE 2 0.0002
184 GASTRITIS EROSIVE 1 0.0002
185 YELLOW SKIN 1 0.0002
186 PHOTOPHOBIA 4 0.0002
187 COLITIS MICROSCOPIC 1 0.0002
188 APHAGIA 1 0.0002
189 HUMERUS FRACTURE 1 0.0002
190 INTERSTITIAL LUNG DISEASE 10 0.0002
191 HORMONE LEVEL ABNORMAL 1 0.0002
192 NASAL POLYPS 1 0.0002
193 PANCREATIC DISORDER 1 0.0002
194 HYPERVOLAEMIA 1 0.0002
195 FLUID INTAKE REDUCED 1 0.0002
196 VEIN DISORDER 1 0.0002
197 APHASIA 6 0.0002
198 VULVOVAGINAL PRURITUS 1 0.0002
199 HIP ARTHROPLASTY 3 0.0002
200 INITIAL INSOMNIA 2 0.0002
201 BASAL CELL CARCINOMA 3 0.0002
202 PRODUCT USE COMPLAINT 3 0.0002
203 FOOD CRAVING 1 0.0002
204 IMPAIRED WORK ABILITY 4 0.0002
205 PRODUCT RESIDUE PRESENT 1 0.0002
206 MUSCLE TIGHTNESS 3 0.0002
207 NORMAL NEWBORN 1 0.0002
208 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
209 DEAFNESS UNILATERAL 1 0.0002
210 HYPERKERATOSIS 1 0.0002
211 NERVE INJURY 2 0.0002
212 PERIORBITAL SWELLING 1 0.0002
213 DERMATITIS CONTACT 2 0.0002
214 MICTURITION URGENCY 2 0.0002
215 EXERCISE TOLERANCE DECREASED 1 0.0002
216 PRODUCT SUBSTITUTION ISSUE 10 0.0002
217 RALES 1 0.0002
218 SPINAL PAIN 2 0.0002
219 URINE ODOUR ABNORMAL 1 0.0002
220 LYMPHOCYTE COUNT DECREASED 3 0.0002
221 ENERGY INCREASED 1 0.0002
222 CATARACT OPERATION 1 0.0002
223 ISCHAEMIC STROKE 3 0.0002
224 THIRST 3 0.0002
225 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
226 NOCTURIA 2 0.0002
227 SPINAL OPERATION 2 0.0002
228 TENDON RUPTURE 2 0.0002
229 GENERALISED OEDEMA 2 0.0002
230 SCREAMING 1 0.0002
231 PROCTALGIA 1 0.0002
232 HAEMOGLOBIN ABNORMAL 1 0.0002
233 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
234 HEPATITIS ACUTE 1 0.0002
235 JOINT STIFFNESS 4 0.0002
236 HYPOGAMMAGLOBULINAEMIA 1 0.0002
237 APPETITE DISORDER 1 0.0002
238 SKIN MASS 1 0.0001
239 QUALITY OF LIFE DECREASED 2 0.0001
240 BREAST MASS 1 0.0001
241 PRODUCT LABEL ISSUE 1 0.0001
242 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
243 ACUTE HEPATIC FAILURE 2 0.0001
244 BLOOD TESTOSTERONE DECREASED 1 0.0001
245 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
246 ONYCHOCLASIS 1 0.0001
247 DROOLING 1 0.0001
248 LYMPHOEDEMA 1 0.0001
249 COORDINATION ABNORMAL 2 0.0001
250 BLOOD TEST ABNORMAL 2 0.0001
251 VISUAL FIELD DEFECT 1 0.0001
252 FLUSHING 14 0.0001
253 RASH PUSTULAR 1 0.0001
254 DYSSTASIA 4 0.0001
255 RESTLESSNESS 5 0.0001
256 THERAPY CESSATION 7 0.0001
257 LABORATORY TEST ABNORMAL 4 0.0001
258 CEREBRAL DISORDER 1 0.0001
259 SKIN HAEMORRHAGE 2 0.0001
260 ARTHROPOD BITE 1 0.0001
261 TOOTH DISORDER 3 0.0001
262 COLON CANCER 2 0.0001
263 HEART RATE IRREGULAR 3 0.0001
264 HEPATIC FAILURE 4 0.0001
265 LACRIMATION INCREASED 4 0.0001
266 TENDON PAIN 1 0.0001
267 BLOOD COUNT ABNORMAL 2 0.0001
268 DISSOCIATION 1 0.0001
269 MUSCLE TWITCHING 3 0.0001
270 APHTHOUS ULCER 1 0.0001
271 EJECTION FRACTION DECREASED 2 0.0001
272 GASTROINTESTINAL INFLAMMATION 1 0.0001
273 DRUG SCREEN POSITIVE 1 0.0001
274 FURUNCLE 1 0.0001
275 BLOOD ALBUMIN DECREASED 1 0.0001
276 RENAL CYST 1 0.0001
277 TRICUSPID VALVE INCOMPETENCE 1 0.0001
278 BLOOD DISORDER 1 0.0001
279 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
280 FRUSTRATION TOLERANCE DECREASED 1 0.0001
281 MUSCLE DISORDER 1 0.0001
282 BLOOD POTASSIUM INCREASED 2 0.0001
283 POST PROCEDURAL INFECTION 1 0.0001
284 PRODUCT DOSE OMISSION 8 0.0001
285 ASPHYXIA 1 0.0001
286 POLYURIA 1 0.0001
287 ABNORMAL FAECES 1 0.0001
288 EYE IRRITATION 7 0.0001
289 ESCHERICHIA INFECTION 1 0.0001
290 PHOTOSENSITIVITY REACTION 2 0.0001
291 VIRAL INFECTION 4 0.0001
292 BLOOD UREA INCREASED 2 0.0001
293 ANGER 4 0.0001
294 NIGHTMARE 4 0.0001
295 CARDIAC MURMUR 1 0.0001
296 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
297 URINE OUTPUT DECREASED 1 0.0001
298 GRIP STRENGTH DECREASED 1 0.0001
299 COLD SWEAT 2 0.0001
300 CARDIAC FAILURE 9 0.0001
301 GOUT 2 0.0001
302 PAIN OF SKIN 3 0.0001
303 END STAGE RENAL DISEASE 2 0.0001
304 NERVE COMPRESSION 1 0.0001
305 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
306 PERSONALITY CHANGE 1 0.0001
307 HEPATIC STEATOSIS 2 0.0001
308 MIDDLE INSOMNIA 2 0.0001
309 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
310 SPINAL DISORDER 1 0.0001
311 PRODUCT PACKAGING ISSUE 1 0.0001
312 INTENTIONAL DOSE OMISSION 3 0.0001
313 MIGRAINE 10 0.0001
314 BALANCE DISORDER 9 0.0001
315 PRESCRIBED OVERDOSE 2 0.0001
316 PLASMA CELL MYELOMA 4 0.0001
317 SKIN FISSURES 2 0.0001
318 THERAPY CHANGE 1 0.0001
319 HOSPICE CARE 1 0.0001
320 LIGAMENT SPRAIN 1 0.0001
321 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
322 EMBEDDED DEVICE 1 0.0001
323 BLADDER DISORDER 1 0.0001
324 SALIVARY HYPERSECRETION 1 0.0001
325 EMPHYSEMA 1 0.0001
326 FLUID RETENTION 5 0.0001
327 TOOTH ABSCESS 1 0.0001
328 BLINDNESS 4 0.0001
329 BLOOD PRESSURE INCREASED 15 0.0001
330 MUSCLE SPASMS 18 0.0001
331 RIB FRACTURE 2 0.0001
332 TEMPERATURE INTOLERANCE 1 0.0001
333 VENTRICULAR EXTRASYSTOLES 1 0.0001
334 POLLAKIURIA 4 0.0001
335 KNEE ARTHROPLASTY 2 0.0001
336 SCRATCH 1 0.0001
337 NEUROPATHY PERIPHERAL 9 0.0001
338 INCONTINENCE 1 0.0001
339 FULL BLOOD COUNT ABNORMAL 1 0.0001
340 RENAL PAIN 1 0.0001
341 MOOD SWINGS 3 0.0001
342 GAIT DISTURBANCE 18 0.0001
343 BREAST PAIN 1 0.0001
344 EPISTAXIS 7 0.0001
345 HEREDITARY ANGIOEDEMA 1 0.0001
346 BREAST CANCER METASTATIC 1 0.0001
347 HOT FLUSH 7 0.0001
348 INTENTIONAL PRODUCT MISUSE 8 0.0001
349 TOOTH FRACTURE 1 0.0001
350 FUNGAL INFECTION 3 0.0001
351 HYPERTENSIVE CRISIS 1 0.0001
352 GLOSSODYNIA 2 0.0001
353 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
354 OCULAR DISCOMFORT 1 0.0001
355 PARAESTHESIA 14 0.0001
356 BLOOD CALCIUM DECREASED 1 0.0001
357 MITRAL VALVE INCOMPETENCE 1 0.0001
358 IMPAIRED DRIVING ABILITY 1 0.0001
359 CHOLECYSTECTOMY 1 0.0001
360 INTERNAL HAEMORRHAGE 1 0.0001
361 HYPOAESTHESIA 13 0.0001
362 RENAL DISORDER 4 0.0001
363 BURNING SENSATION 6 0.0001
364 BLOOD IRON DECREASED 1 0.0001
365 CATARACT 5 0.0001
366 MACULAR DEGENERATION 1 0.0001
367 MUSCLE RIGIDITY 1 0.0001
368 WRIST FRACTURE 1 0.0001
369 LOCALISED INFECTION 2 0.0001
370 ABDOMINAL PAIN UPPER 17 0.0001
371 CRYING 3 0.0001
372 VERTIGO 5 0.0001
373 NO THERAPEUTIC RESPONSE 1 0.0001
374 FEELING HOT 5 0.0001
375 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
376 CARDIOMEGALY 1 0.0001
377 HYPERCALCAEMIA 1 0.0001
378 ABASIA 2 0.0001
379 EYE SWELLING 3 0.0001
380 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
381 HAIR COLOUR CHANGES 1 0.0001
382 AGEUSIA 2 0.0001
383 VISION BLURRED 11 0.0001
384 INJECTION SITE DISCOLOURATION 1 0.0001
385 MUSCULOSKELETAL STIFFNESS 7 0.0001
386 CHRONIC KIDNEY DISEASE 6 0.0001
387 PRODUCT COMPLAINT 2 0.0001
388 MUSCLE ATROPHY 1 0.0001
389 INTRAOCULAR PRESSURE INCREASED 1 0.0001
390 GASTROINTESTINAL DISORDER 7 0.0001
391 SKIN ULCER 2 0.0001
392 RASH GENERALISED 2 0.0001
393 AMNESIA 5 0.0001
394 SEDATION 2 0.0001
395 IMMUNE SYSTEM DISORDER 1 0.0001
396 TOOTH INFECTION 1 0.0001
397 PULMONARY CONGESTION 1 0.0001
398 HAIR TEXTURE ABNORMAL 1 0.0001
399 FEAR 2 0.0001
400 THROAT TIGHTNESS 2 0.0001
401 PRODUCT TASTE ABNORMAL 1 0.0001
402 DRUG TOXICITY 1 0.0001
403 GINGIVAL BLEEDING 1 0.0001
404 PERIPHERAL COLDNESS 1 0.0001
405 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
406 CONTUSION 7 0.0001
407 DRUG INTOLERANCE 7 0.0001
408 ABNORMAL DREAMS 2 0.0001
409 ORAL DISCOMFORT 1 0.0001
410 NECK PAIN 4 0.0001
411 WEIGHT INCREASED 16 0.0001
412 CARPAL TUNNEL SYNDROME 1 0.0001
413 ALOPECIA 14 0.0001
414 PAIN IN EXTREMITY 21 0.0001
415 DYSPEPSIA 7 0.0001
416 SLEEP DISORDER 5 0.0001
417 LYMPHOPENIA 1 0.0001
418 DEPRESSION 16 0.0001
419 MOBILITY DECREASED 5 0.0001
420 MYELODYSPLASTIC SYNDROME 1 0.0001
421 ANOSMIA 1 0.0001
422 HYPERTHYROIDISM 1 0.0001
423 CONSTIPATION 15 0.0001
424 APATHY 1 0.0001
425 PALPITATIONS 8 0.0001
426 SURGERY 4 0.0001
427 CONFUSIONAL STATE 11 0.0001
428 ILLNESS 7 0.0001
429 ACUTE MYOCARDIAL INFARCTION 2 0.0001
430 LIVER DISORDER 3 0.0001
431 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
432 ARTHRALGIA 28 0.0001
433 BLOOD POTASSIUM DECREASED 2 0.0001
434 HYPOAESTHESIA ORAL 1 0.0001
435 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
436 DISCOMFORT 4 0.0001
437 DRUG DISPENSING ERROR 1 0.0001
438 PHARYNGEAL OEDEMA 1 0.0001
439 PERIPHERAL SWELLING 10 0.0001
440 THYROID DISORDER 1 0.0001
441 OROPHARYNGEAL PAIN 6 0.0001
442 MUSCULOSKELETAL CHEST PAIN 1 0.0001
443 COGNITIVE DISORDER 3 0.0001
444 SWOLLEN TONGUE 2 0.0001
445 ARTHRITIS 5 0.0001
446 OCULAR HYPERAEMIA 3 0.0001
447 COMA 3 0.0001
448 MULTIPLE SCLEROSIS 3 0.0001
449 SCIATICA 1 0.0001
450 ABSCESS 1 0.0001
451 HYPOTHYROIDISM 2 0.0001
452 FEELING ABNORMAL 15 0.0001
453 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
454 NIGHT SWEATS 2 0.0001
455 BACK DISORDER 1 0.0001
456 METASTASES TO BONE 1 0.0001
457 WEIGHT DECREASED 17 0.0001
458 INFLUENZA LIKE ILLNESS 5 0.0001
459 VENTRICULAR TACHYCARDIA 1 0.0001
460 TREMOR 10 0.0001
461 PAIN 37 0.0001
462 DRY EYE 3 0.0001
463 INSOMNIA 16 0.0001
464 SKIN DISORDER 2 0.0001
465 AGGRESSION 3 0.0001
466 CHILLS 7 0.0001
467 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
468 SKIN EXFOLIATION 5 0.0001
469 HEMIPARESIS 1 0.0001
470 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
471 MYALGIA 10 0.0001
472 METRORRHAGIA 1 0.0001
473 CHEST DISCOMFORT 6 0.0001
474 MUSCULOSKELETAL DISCOMFORT 1 0.0001
475 MULTI-ORGAN FAILURE 1 0.0001
476 DELIRIUM 2 0.0001
477 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
478 SPEECH DISORDER 3 0.0001
479 DEVICE USE ISSUE 1 0.0001
480 AMENORRHOEA 1 0.0001
481 HEART RATE DECREASED 2 0.0001
482 LYMPHADENOPATHY 2 0.0001
483 VISUAL IMPAIRMENT 7 0.0001
484 HEAD DISCOMFORT 1 0.0001
485 DISTURBANCE IN ATTENTION 3 0.0001
486 TOOTHACHE 1 0.0001
487 OSTEOMYELITIS 1 0.0001
488 RESTLESS LEGS SYNDROME 1 0.0001
489 C-REACTIVE PROTEIN INCREASED 2 0.0001
490 BONE DISORDER 1 0.0001
491 PANIC ATTACK 2 0.0001
492 SUICIDAL IDEATION 5 0.0001
493 PRODUCT DOSE OMISSION ISSUE 16 0.0001
494 HEADACHE 34 0.0001
495 BLOOD GLUCOSE ABNORMAL 1 0.0001
496 DIZZINESS 27 0.0001
497 FALL 18 0.0001
498 ARTHROPATHY 3 0.0001
499 CONJUNCTIVITIS 1 0.0001
500 DYSGEUSIA 4 0.0001
501 THINKING ABNORMAL 1 0.0001
502 SWELLING 5 0.0001
503 BLISTER 3 0.0001
504 BLOOD SODIUM DECREASED 1 0.0001
505 FOOT FRACTURE 1 0.0001
506 BLOOD URINE PRESENT 1 0.0001
507 MUSCULOSKELETAL DISORDER 1 0.0001
508 FEELING JITTERY 1 0.0001
509 SLEEP APNOEA SYNDROME 1 0.0001
510 LETHARGY 3 0.0001
511 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
512 SEIZURE 6 0.0001
513 GLAUCOMA 1 0.0001
514 ERUCTATION 1 0.0001
515 DYSTONIA 1 0.0001
516 DIARRHOEA 33 0.0001
517 NASAL CONGESTION 3 0.0001
518 MEMORY IMPAIRMENT 7 0.0001
519 UPPER LIMB FRACTURE 1 0.0001
520 THROMBOSIS 4 0.0000
521 JOINT SWELLING 6 0.0000
522 FULL BLOOD COUNT DECREASED 1 0.0000
523 PRODUCT PHYSICAL ISSUE 1 0.0000
524 STOMATITIS 3 0.0000
525 EXTRA DOSE ADMINISTERED 2 0.0000
526 PSORIATIC ARTHROPATHY 2 0.0000
527 OSTEOPOROSIS 2 0.0000
528 INJECTION SITE WARMTH 1 0.0000
529 CHEST PAIN 9 0.0000
530 TOOTH LOSS 1 0.0000
531 PULMONARY HYPERTENSION 1 0.0000
532 ASTHENIA 18 0.0000
533 HAEMORRHAGE 5 0.0000
534 URTICARIA 8 0.0000
535 OSTEOARTHRITIS 2 0.0000
536 EATING DISORDER 1 0.0000
537 RETCHING 1 0.0000
538 HYPERHIDROSIS 6 0.0000
539 RECTAL HAEMORRHAGE 2 0.0000
540 HYPOACUSIS 2 0.0000
541 POOR QUALITY SLEEP 1 0.0000
542 PRURITUS GENERALISED 1 0.0000
543 MENTAL DISORDER 2 0.0000
544 PRODUCT PRESCRIBING ISSUE 1 0.0000
545 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
546 MELAENA 1 0.0000
547 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
548 THROAT IRRITATION 2 0.0000
549 ADVERSE DRUG REACTION 4 0.0000
550 CHROMATURIA 1 0.0000
551 HEPATIC ENZYME INCREASED 3 0.0000
552 MUSCULAR WEAKNESS 5 0.0000
553 SKIN IRRITATION 2 0.0000
554 NEPHROLITHIASIS 2 0.0000
555 TINNITUS 2 0.0000
556 SHOCK 1 0.0000
557 PERICARDIAL EFFUSION 1 0.0000
558 PNEUMONIA 14 0.0000
559 DECREASED APPETITE 10 0.0000
560 BACK PAIN 10 0.0000
561 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
562 DRUG DOSE OMISSION 7 0.0000
563 DYSPHAGIA 4 0.0000
564 DISEASE RECURRENCE 2 0.0000
565 RASH ERYTHEMATOUS 2 0.0000
566 ABDOMINAL DISCOMFORT 7 0.0000
567 HEPATIC CANCER 1 0.0000
568 MENTAL IMPAIRMENT 1 0.0000
569 FIBROMYALGIA 1 0.0000
570 ATRIAL FIBRILLATION 4 0.0000
571 MALAISE 18 0.0000
572 AGITATION 3 0.0000
573 LUNG DISORDER 2 0.0000
574 INJECTION SITE URTICARIA 1 0.0000
575 NAUSEA 32 0.0000
576 OSTEONECROSIS OF JAW 1 0.0000
577 HEART RATE INCREASED 4 0.0000
578 COVID-19 7 0.0000
579 FATIGUE 31 0.0000
580 HALLUCINATION 3 0.0000
581 ACNE 3 0.0000
582 ABDOMINAL PAIN LOWER 1 0.0000
583 PRURITUS 15 0.0000
584 DIPLOPIA 1 0.0000
585 RESPIRATORY TRACT INFECTION 1 0.0000
586 NERVOUSNESS 2 0.0000
587 DEAFNESS 1 0.0000
588 MUSCULOSKELETAL PAIN 2 0.0000
589 NASOPHARYNGITIS 7 0.0000
590 DEPRESSED MOOD 2 0.0000
591 DRUG INTERACTION 6 0.0000
592 HYPERSENSITIVITY 7 0.0000
593 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
594 INJECTION SITE BRUISING 3 0.0000
595 EAR INFECTION 1 0.0000
596 DEHYDRATION 5 0.0000
597 BREAST CANCER FEMALE 1 0.0000
598 CARDIAC FAILURE CONGESTIVE 3 0.0000
599 FREQUENT BOWEL MOVEMENTS 1 0.0000
600 DRY MOUTH 3 0.0000
601 RASH PRURITIC 2 0.0000
602 OEDEMA 2 0.0000
603 LIMB INJURY 1 0.0000
604 TREATMENT NONCOMPLIANCE 2 0.0000
605 RESPIRATORY DISTRESS 1 0.0000
606 DIVERTICULITIS 1 0.0000
607 FEELING COLD 1 0.0000
608 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
609 INFLUENZA 4 0.0000
610 HAEMOPTYSIS 1 0.0000
611 DEMENTIA 1 0.0000
612 WOUND 1 0.0000
613 PAIN IN JAW 1 0.0000
614 HYPERSOMNIA 1 0.0000
615 PANCREATIC CARCINOMA 1 0.0000
616 DYSPHONIA 2 0.0000
617 BONE PAIN 2 0.0000
618 URINARY INCONTINENCE 1 0.0000
619 DYSPNOEA 19 0.0000
620 SUICIDE ATTEMPT 2 0.0000
621 ILL-DEFINED DISORDER 2 0.0000
622 PLEURAL EFFUSION 2 0.0000
623 EPILEPSY 1 0.0000
624 ACUTE KIDNEY INJURY 5 0.0000
625 DRUG ADMINISTRATION ERROR 1 0.0000
626 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
627 ADVERSE EVENT 3 0.0000
628 HOSPITALISATION 5 0.0000
629 EMOTIONAL DISORDER 1 0.0000
630 LIMB DISCOMFORT 1 0.0000
631 FEMUR FRACTURE 1 0.0000
632 NERVOUS SYSTEM DISORDER 1 0.0000
633 PRODUCT USE ISSUE 6 0.0000
634 BLOOD GLUCOSE INCREASED 6 0.0000
635 ANXIETY 9 0.0000
636 CYSTITIS 1 0.0000
637 LOSS OF CONSCIOUSNESS 4 0.0000
638 MOVEMENT DISORDER 1 0.0000
639 HIP FRACTURE 1 0.0000
640 RHINORRHOEA 2 0.0000
641 DEEP VEIN THROMBOSIS 2 0.0000
642 PSORIASIS 4 0.0000
643 IMPAIRED HEALING 1 0.0000
644 EYE DISORDER 1 0.0000
645 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
646 RENAL FAILURE 4 0.0000
647 VISUAL ACUITY REDUCED 1 0.0000
648 EXPIRED PRODUCT ADMINISTERED 1 0.0000
649 LIP SWELLING 1 0.0000
650 URINARY RETENTION 1 0.0000
651 GAIT INABILITY 1 0.0000
652 HYPOTENSION 6 0.0000
653 RASH 13 0.0000
654 SOMNOLENCE 6 0.0000
655 VOMITING 14 0.0000
656 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
657 CONDITION AGGRAVATED 9 0.0000
658 PRODUCT QUALITY ISSUE 4 0.0000
659 URINARY TRACT INFECTION 5 0.0000
660 SINUSITIS 3 0.0000
661 HAEMATURIA 1 0.0000
662 GASTRIC DISORDER 1 0.0000
663 MYOCARDIAL INFARCTION 5 0.0000
664 COUGH 8 0.0000
665 HYPERKALAEMIA 1 0.0000
666 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
667 PLATELET COUNT DECREASED 3 0.0000
668 THERAPY INTERRUPTED 2 0.0000
669 CEREBRAL HAEMORRHAGE 1 0.0000
670 INFECTION 4 0.0000
671 HYPERGLYCAEMIA 1 0.0000
672 UNDERDOSE 2 0.0000
673 ACCIDENTAL OVERDOSE 1 0.0000
674 DYSURIA 1 0.0000
675 INJECTION SITE MASS 1 0.0000
676 DYSARTHRIA 1 0.0000
677 DYSPNOEA EXERTIONAL 1 0.0000
678 ASTHMA 3 0.0000
679 INTESTINAL OBSTRUCTION 1 0.0000
680 RHEUMATOID ARTHRITIS 3 0.0000
681 COLITIS 1 0.0000
682 ANAEMIA 5 0.0000
683 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
684 ABNORMAL BEHAVIOUR 1 0.0000
685 DISORIENTATION 1 0.0000
686 OEDEMA PERIPHERAL 3 0.0000
687 DYSKINESIA 1 0.0000
688 NEUTROPHIL COUNT DECREASED 1 0.0000
689 LUNG NEOPLASM MALIGNANT 1 0.0000
690 TREATMENT FAILURE 2 0.0000
691 RHABDOMYOLYSIS 1 0.0000
692 WITHDRAWAL SYNDROME 1 0.0000
693 CEREBROVASCULAR ACCIDENT 4 0.0000
694 RENAL FAILURE ACUTE 1 0.0000
695 DEVICE DISLOCATION 1 0.0000
696 SEPTIC SHOCK 1 0.0000
697 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
698 ANGIOEDEMA 1 0.0000
699 TACHYCARDIA 2 0.0000
700 DRY SKIN 3 0.0000
701 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
702 DEVICE ISSUE 2 0.0000
703 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
704 THERAPY NON-RESPONDER 1 0.0000
705 SKIN DISCOLOURATION 1 0.0000
706 HYPOKALAEMIA 1 0.0000
707 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
708 CARDIAC DISORDER 2 0.0000
709 COLORECTAL CANCER 1 0.0000
710 PRODUCTIVE COUGH 1 0.0000
711 BLOOD GLUCOSE DECREASED 1 0.0000
712 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
713 CELLULITIS 1 0.0000
714 PANCREATITIS 1 0.0000
715 BRADYCARDIA 1 0.0000
716 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
717 HAEMATOCHEZIA 1 0.0000
718 SEPSIS 2 0.0000
719 FLATULENCE 1 0.0000
720 DEATH 15 0.0000
721 HERPES ZOSTER 1 0.0000
722 PYREXIA 6 0.0000
723 ABDOMINAL PAIN 4 0.0000
724 OFF LABEL USE 15 0.0000
725 DISEASE PROGRESSION 2 0.0000
726 IRRITABILITY 1 0.0000
727 THERAPEUTIC RESPONSE DECREASED 1 0.0000
728 INJECTION SITE ERYTHEMA 2 0.0000
729 EXPOSURE DURING PREGNANCY 1 0.0000
730 SWELLING FACE 1 0.0000
731 BLOOD PRESSURE DECREASED 1 0.0000
732 NEOPLASM MALIGNANT 1 0.0000
733 INJECTION SITE PRURITUS 1 0.0000
734 INJECTION SITE REACTION 1 0.0000
735 DRUG INEFFECTIVE 19 0.0000
736 DEVICE MALFUNCTION 1 0.0000
737 INJURY 1 0.0000
738 HYPERTENSION 3 0.0000
739 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
740 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
741 SKIN BURNING SENSATION 1 0.0000
742 OVERDOSE 3 0.0000
743 BRONCHITIS 1 0.0000
744 INCORRECT DOSE ADMINISTERED 3 0.0000
745 DIABETES MELLITUS 1 0.0000
746 PROSTATE CANCER 1 0.0000
747 CARDIAC ARREST 1 0.0000
748 DRUG ABUSE 1 0.0000
749 DRUG WITHDRAWAL SYNDROME 1 0.0000
750 BREAST CANCER 1 0.0000
751 PULMONARY EMBOLISM 1 0.0000
752 SYNCOPE 1 0.0000
753 ERYTHEMA 2 0.0000
754 ABDOMINAL DISTENSION 1 0.0000
755 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
756 NEUTROPENIA 1 0.0000
757 TOXICITY TO VARIOUS AGENTS 1 0.0000
758 NO ADVERSE EVENT 1 0.0000
759 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
760 INJECTION SITE PAIN 1 0.0000